DailyStocks Stock Article Search

https://www.zacks.com/commentary/2237064/top-research-reports-for-adobe-united-parcel-deere?cid=CS-ZC-FT-research_daily-2237064 Mar 07, 2024 - Today's Research Daily features new research reports on 16 major stocks, including Adobe Inc. (ADBE), United Parcel Service, Inc. (UPS) and Deere & Company (DE). 0

https://www.zacks.com/stock/news/2236145/gsk-vs-vrtx-which-stock-is-the-better-value-option?cid=CS-ZC-FT-tale_of_the_tape|yseop_template_3-2236145 Mar 05, 2024 - GSK vs. VRTX: Which Stock Is the Better Value Option? 0

https://seekingalpha.com/news/4075698-guggenheim-upgrades-gsk-to-buy-from-neutral?source=feed_sector_healthcare Mar 04, 2024 - Guggenheim upgrades GSK (GSK) stock to buy, citing higher revenue estimates, improving margins, and potential resolution of the Zantac overhang. Read more here. 0

https://seekingalpha.com/news/4075584-sen-warren-accuses-gsk-of-price-gouging-over-pediatric-asthma-drug?source=feed_sector_healthcare Mar 04, 2024 - U.S. Sen. Elizabeth Warren has slammed GSK (GSK) for alleged price-gouging over the marketing of its pediatric asthma drug Flovent HFA and its authorized generic. Read more here. 0

https://www.zacks.com/stock/news/2234243/gsk-gsk-stock-declines-while-market-improves-some-information-for-investors?cid=CS-ZC-FT-tale_of_the_tape|yseop_template_6v2-2234243 Feb 29, 2024 - In the most recent trading session, GSK (GSK) closed at $41.90, indicating a -1.04% shift from the previous trading day. 0

https://www.cnbc.com/2024/02/29/pfizer-rsv-vaccine-protects-older-adults-over-two-seasons.html Feb 29, 2024 - The results come ahead of a meeting of an advisory panel to the CDC, which will consider whether seniors should take RSV shots annually or every other year. 0

https://www.zacks.com/stock/news/2233246/here-s-why-gsk-gsk-is-a-strong-momentum-stock?cid=CS-ZC-FT-tale_of_the_tape|zacks_education_momentum_score-2233246 Feb 28, 2024 - Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service. 0

https://www.zacks.com/stock/news/2232453/here-s-why-gsk-gsk-is-a-strong-value-stock?cid=CS-ZC-FT-tale_of_the_tape|zacks_education_value_score-2232453 Feb 27, 2024 - The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage. 0

https://www.zacks.com/stock/news/2231922/all-you-need-to-know-about-glaxo-gsk-rating-upgrade-to-buy?cid=CS-ZC-FT-tale_of_the_tape|yseop_template_12_zacks_rank_upgrade-2231922 Feb 26, 2024 - Glaxo (GSK) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy). 0

https://www.zacks.com/stock/news/2231706/are-medical-stocks-lagging-gsk-plc-sponsored-adr-gsk-this-year?cid=CS-ZC-FT-tale_of_the_tape|yseop_template_1-2231706 Feb 26, 2024 - Here is how GSK (GSK) and Akero Therapeutics, Inc. (AKRO) have performed compared to their sector so far this year. 0